Global Naloxone Market Size Study By Product (Spray Forms, and Injectable Forms), By Application (Opioid Overdose, and Preventing Opioid Abuse, and Others), and By Regional (North America, Europe, Asia Pacific, Latin America, and Rest of the World) Forecasts, 2018-2025
-
Product Code:
RP-ID-10013133 -
Published Date:
21 Oct 2022 -
Region:
Global
-
Pages:
180 -
Category:
Healthcare & Pharmaceuticals -
Publisher:
Pub-ID-14
Impact Analysis on the Growth of Market
Inflation and Looming Recession to Haunt Businesses:
In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.
....
The Research Report is Updated with 2022 Base Year, 2023 Estimated year and Forecast till 2035 with Market Insights.
With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2022 as base year, 2023 as estimated year and forecast to 2035. This will have market drivers, recovery rate in the market, insights and competitive analysis.
Market Overview:
Translate Report
Global Naloxone Market to reach USD XXX million by 2025.
Global Naloxone Market valued approximately USD XXX million in 2016 is forecasted to grow with a healthy growth rate of more than XX% over the forecast period 2018-2025. The major factors speculated to augment the markets rising availability of naloxone as a generic drug, and death cases from drug overdose increasing with alarmingly escalating rates. Continuous increase in prices of naloxone drug is a major constraint for the growth in market. Escalating engagement of private organizations and government in spreading cognizance regarding the availability of naloxone is a prime opportunity for growth in the market. Naloxone is a generic drug which is used to blocks or reverses the effects of opioid medication, including extreme drowsiness, slowed breathing, or loss of consciousness.
The regional analysis of Global Naloxone Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of market share. Furthermore, owing to countries such as China, India, and Japan, Asia Pacific region is also expected to exhibit higher growth rate / CAGR over the forecast period 2018-2025.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
 Spray Forms
 Injectable Forms
By Application:
 Opioid Overdose
 Preventing Opioid Abuse
 Others
By Regions:
 North America
o U.S.
o Canada
 Europe
o UK
o Germany
 Asia Pacific
o China
o India
o Japan
 Latin America
o Brazil
o Mexico
 Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2015, 2016
Base year - 2017
Forecast period - 2018 to 2025
The industry is seeming to be fairly competitive. Some of the leading market players include Amphastar Pharmaceuticals, Pfizer, ADAPT Pharma, Kaleo, Sandoz, Amneal Pharmaceuticals, West Ward Pharmaceuticals, Mylan, Angkor Data Communication Group Co., Ltd., Cybercomm, Route Mobile Limited, Infobip Ltd., Tyntec, Nexmo, DIMOCO and so on. The fierce competitiveness has made these players spend in product developments to improve the customer's requirements.
Target Audience of the Naloxone Market Study:
 Key Consulting Companies & Advisors
 Large, medium-sized, and small enterprises
 Venture capitalists
 Value-Added Resellers (VARs)
 Third-party knowledge providers
 Investment bankers
 Investors
Geography Analysis:
The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:
- North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys & Opportunity Outlook
- Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook
.
Please enter your personal details below
Overview
Financial (Subject to Data Availability)
Product Summary
Pfizer
ADAPT Pharma
Kaleo
Sandoz
Amneal Pharmaceuticals
West Ward Pharmaceuticals
Mylan
Angkor Data Communication Group Co., Ltd.
Cybercomm
Route Mobile Limited
Infobip Ltd.
Tyntec
Nexmo
DIMOCO